Virtual Medicinal Product (VMP)
-
Tazarotene 0.1% gel
Name Details
|
Current Name
Tazarotene 0.1% gel
|
Start Date
18-02-2003
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Cutaneous
- Form
- Cutaneous gel
- Ontology Form/Route
- gel.cutaneous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
D05AX05
| BNF |
|
Current BNF
13050200
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
13050200
|
Start Date
23-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 35915011000001104 |
19-10-2018 |
|
| 332220004 |
18-02-2003 |
18-10-2018 |
VMP Ingredients
VMP ingredients table
| Tazarotene |
Based on Ingredient Substance |
|
1 mg |
1 gram |
Name
Tazarotene
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
1
Strength and UOM (Dmr)
1
Virtual Medicinal Product Pack (VMPP) Information